Life Sciences - Healthcare News | October 2023
Innovative start-ups are booming in Germany's attractive life sciences sector.
Your company is already operating in Germany and you would now like to export worldwide?
Innovative start-ups are booming in Germany's attractive life sciences sector.
Therapeutics and autonomous driving, recycling and space junk, are all part of our regular survey of some of the most interesting developments in German research and development.
Japanese pharmaceuticals giant Takeda has put hundreds of millions of euros in recent years into its location in the southwestern German town of Singen to produce its anti-dengue-fever vaccine “Qdenga.”
The mood in German pharmaceuticals is bright, with companies looking to increase investment.
A quartet of young German companies have secured nine-figure financing rounds. Here’s our bimonthly round-up of some of the largest venture-capital deals in Germany.
Germany's research and development (R&D) landscape is second to none in the EU- whether it be practical, theoretical or industrial research. Here’s a round of some of the latest R&D breakthroughs “Made in Germany.”
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.
Germany's regions in structural change are proving attractive with international investors, with numerous new developments announced in recent months.
This year’s Nobel Prize for Physiology or Medicine has been awarded to Svante Pääbo, Director of the Max Planck Institute for Evolutionary Anthropology in Leipzig - underlining once more the importance of Germany as an international location for fundamental research.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.